Covid vaccine trials have started in Australia -

Coronavirus vaccine trial patients to earn $2350

The Aussies doing the first clinical trial for a coronavirus vaccine get a decent sum for their time — but there are lots of rules they need to follow.

Australians taking part in one of the world’s first coronavirus vaccine trials will get up to $2350 for their time — but their participation comes with many rules.

For starters, guinea pigs have to commit to a two-year time frame.

Clinical research company Linear is conducting the phase 1 trial of a COVID-19 vaccine in humans in Perth.

The company needs 150 participants initially and they all need to be fit and healthy and pass several tests during the screening process.

If they’re chosen to take part, they will need to avoid too much alcohol, cannot do drugs or do too much exercise.

Participants have to monitor their symptoms for a week after they get the injection, before getting a second dose 21 days later.

“I feel fine, I feel completely normal,” Rachelle Kalic told the 7.30 report after taking part.

“There’s no pain, there’s no swelling, I feel fighting fit.”

Ms Kalic said she wanted to take part because she believed developing a vaccine was likely the only way things can return to normal.

The Linear process has been fast-tracked, using a vaccine candidate developed by Chinese company Clover Biopharmaceuticals.

Linear associate medical director Lara Hatchuel said the hope was participants would build up a strong immune response so if they were infected with the virus their body knew what to do.

“A small proportion of our participants will get a placebo,” she told 7.30.

“The investigator, the study teams, the clinic team and the participant are not aware of whether they have received a placebo or the vaccine itself.”

There are now 17 vaccines that have reached the clinical evaluation stage around the world, with more than 100 that are preclinical.

This vaccine is similar to several others, including the one developed by the University of Queensland.

Global biotechnology company CSL will further develop, manufacture and distribute UQ’s COVID-19 vaccine candidate.

Early preclinical trials showed that their vaccine candidate produced high levels of antibodies that can neutralise the virus, with phase 1 safety trials set to happen in Brisbane this month.

Should clinical trials be successful, a vaccine could be available in 2021.

https://www.news.com.au/lifestyle/health/health-problems/coronavirus-vaccine-trial-patients-to-earn-2350/news-story/dd02669a91e2e86d37dbe62cacbcd3b8

Of course, they are targeting low income earners.